INOVIO Pharmaceuticals, Inc. (INOVIO) is a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat, cure and protect people from infectious diseases, cancer and HPV-associated diseases.
INOVIO’s DNA medicines platform and proprietary smart device can target virtually any DNA sequence. With 15 clinical programs currently in development, INOVIO has the potential to save and protect lives worldwide and power a new decade of DNA medicines.
For more information, visit www.inovio.com.
|
|
|
201-500 employees
View all Inovio Pharmaceuticals Inc. employees
|
|
Biotechnology
|
|
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, US
|
|
1983
|
|
Hiv, Prostate Cancer, Immuno-Oncology, Immunotherapy, Cancer, Ebola, Infectious Diseases, Cervical Dysplasia, Dna Vaccines, Zika, Electroporation, Cervical Cancer, Mers, T Cells, Glioblastoma, Head And Neck Cancer, Lassa, Covid-19, Cellectra, Dna Medicines, Dna Plasmids, Hpv-Associated Cancers, Hpv-Associated Disease, Syncon, Anal Hsil, Cervical Hsil, Coronaviruses, Dmab (Dna-Encoded Monoclonal Antibodies), High-Risk Hpv, Recurrent Respiratory Papillomatosis (Rrp), Vulvar Hsil
|
Jacqueline Shea is the CEO of INOVIO Pharmaceuticals, Inc.. To contact Jacqueline Shea email at [email protected]. Or you may call 8327683076
The decision makers in INOVIO Pharmaceuticals, Inc. are Amanda Bezon, Ej Brandreth, Jacqueline Shea, etc. Click to Find INOVIO Pharmaceuticals, Inc. decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.